POTENTIATION OF MEROCYANINE 540-MEDIATED PHOTODYNAMIC THERAPY BY SALICYLATE and RELATED DRUGS
- 1 October 1995
- journal article
- research article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 62 (4), 790-799
- https://doi.org/10.1111/j.1751-1097.1995.tb08731.x
Abstract
Simultaneous exposure to merocyanine 540 (MC540) and light of a suitable wavelength kills leukemia, lymphoma and neuroblastoma cells but is relatively well tolerated by normal pluripotent hematopoietic stem cells. This differential phototoxic effect has been exploited in preclinical models and a phase I clinical trial for the extracorporeal purging of autologous bone marrow grafts. Salicylate is known to potentiate the MC540-mediated photokilling of tumor cells. Assuming that salicylate induces a change in the plasma membrane of tumor cells (but not normal hematopoietic stem cells) that enhances the binding of dye molecules it has been suggested that salicylate may provide a simple and effective means of improving the therapeutic index of MC540-mediated photodynamic therapy. We report here on a direct test of this hypothesis in a murine model of bone marrow transplantation as well as in clonal cultures of normal murine hematopoietic progenitor cells. In both systems, salicylate enhanced the MC540-sensitized photoinactivation of leukemia cells and normal bone marrow cells to a similar extent and thus failed to improve the therapeutic index of MC540 significantly. On the basis of a series of dye-binding studies, we offer an alternative explanation for the potentiating effect of salicylate. Rather than invoking a salicylate-induced change in the plasma membrane of tumor cells, we propose that salicylate displaces dye molecules from serum albumin, thereby enhancing the concentration of free (active) dye available for binding to tumor as well as normal hematopoietic stem cells.Keywords
This publication has 22 references indexed in Scilit:
- Bone Marrow Transplantation—Past, Present and FutureScandinavian Journal of Immunology, 1994
- The role of serum and serum components in the merocyanine 540-sensitized photoinactivation of K562 leukemia cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 1992
- MEROCYANINE 540‐SENSITIZED PHOTOINACTIVATION OF LEUKEMIA CELLS: EFFECTS OF DOSE FRACTIONATIONPhotochemistry and Photobiology, 1992
- Singlet oxygen production and fluorescence yields of merocyanine 540: a comparative study in solution and model membrane systemsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- MODULATION BY THIOLS OF THE MEROCYANINE 540‐SENSITIZED PHOTOLYSIS OF LEUKEMIA CELLS, RED CELLS, AND Herpes simplex VIRUS TYPE 1Photochemistry and Photobiology, 1991
- Bone marrow autotransplantationAmerican Journal Of Medicine, 1989
- Autologous Bone Marrow TransplantationAnnual Review of Medicine, 1989
- Susceptibility to merocyanine 540‐mediated photosensitization: A differentiation marker on murine hematopoietic progenitor cellsJournal of Cellular Physiology, 1983
- Merocyanine 540 as a fluorescent probe of membranes: Staining of electrically excitable cellsCell, 1978
- Merocyanine 540 as a fluorescent probe of membranes: Selective staining of leukemic and immature hemopoietic cellsCell, 1978